TY - JOUR
T1 - Novel interactions between second messengers in rat basophilic leukaemia (RBL-1) cells
AU - Galadari, S. H.I.
AU - Morris, H. R.
AU - Di Marzo, V.
PY - 1990
Y1 - 1990
N2 - As a continuation of our efforts to understand leukotriene biosynthesis mechanisms, we have studied the effect on RBL-1 cells of a series of phospholipase C (PLC) and phospholipase A2 (PLA2) activators including calcium ionophore (A23187), leukotriene D4 (LTD4), PAF, fMLP and bradykinin. LTD4 and A23187 (the latter only at 20 uM concentration and only after a 45 min incubation time) were shown to induce phosphoinositide (PI) breakdown, whilst A23187 induced leukotriene biosynthesis. For the first time it was shown that cAMP analogues markedly inhibit LTD4-induced IP formation. Moreover, the 5-lipoxygenase inhibitor AA861 abolished the ionophore-induced PI breakdown, thus suggesting that this effect is a novel example of PLC activation following PLA2 activation and 5-lipoxygenase-derived metabolite production.
AB - As a continuation of our efforts to understand leukotriene biosynthesis mechanisms, we have studied the effect on RBL-1 cells of a series of phospholipase C (PLC) and phospholipase A2 (PLA2) activators including calcium ionophore (A23187), leukotriene D4 (LTD4), PAF, fMLP and bradykinin. LTD4 and A23187 (the latter only at 20 uM concentration and only after a 45 min incubation time) were shown to induce phosphoinositide (PI) breakdown, whilst A23187 induced leukotriene biosynthesis. For the first time it was shown that cAMP analogues markedly inhibit LTD4-induced IP formation. Moreover, the 5-lipoxygenase inhibitor AA861 abolished the ionophore-induced PI breakdown, thus suggesting that this effect is a novel example of PLC activation following PLA2 activation and 5-lipoxygenase-derived metabolite production.
UR - http://www.scopus.com/inward/record.url?scp=0025668637&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025668637&partnerID=8YFLogxK
M3 - Article
C2 - 1965279
AN - SCOPUS:0025668637
SN - 0158-5231
VL - 22
SP - 379
EP - 386
JO - Biochemistry International
JF - Biochemistry International
IS - 2
ER -